课题基金 / 基金详情

Association of gene expression involving innate immunity and genetic variation in IL28B with antiviral response

Association of gene expression involving innate immunity and genetic variation in IL28B with antiviral response
IL28B 中涉及先天免疫和遗传变异的基因表达与抗病毒反应的关联
批准号:
20590769
负责人:
ASAHINA Yasuhiro
金额:
$3.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

ASAHINA Yasuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
Innate immunity plays an important role in host antiviral response to hepatitis C viral (HCV) infection。最近,IL 28 B的单核苷多态性(SNP)和宿主响应到pegylated interferon·(PEG-IFN·)和ribavirin (RBV) were shown to be strongly associated。We aimed to determine the gene expression involving innate immunity in IL32B genotypes and elucidate its relation to response to antiviral treatment。我们用PEG-IFN·-2b/RBV和病毒传感器量化表达(RIG-I、MDA 5和LGP 2)、适配器分子(IPS-1)、相关泛素E3-配酶(RNF 125)、调制器(ISG 15和USP 18)和IL 28(IFN·)处理了88个慢性肝炎C患者的基因型IL 28 B SNP(rs 809917和rs 12979860)。两种IL 28 B SNPs均为100%唯一; 54名患者接受RS 809917 TT/RS 12979860 CC (IL 28 B主要患者)和34名RS 809917 TG/RS 12979860 CT (IL 28 B次要患者)。IL32B minor patients were significantly up-regulated compared with that in IL32B major patients (~3.3 fold, p<0.001)。However,IPS-1在IL 28 B小患者中明显较低(1.2折叠, p=0.028)。病毒传感器和调制器的Hepatic expressions of viral sensors and modulators were significantly higher in non-virological responders (NVR) than that in others despite stratification by IL 28 B genotype (~2)。6 fold, p<0.001)。多变量和ROC分析表明了RIG-I和ISG 15表达式和RIG-I/IPS-1表达式比是NVR的独立因素。Conclusion : Gene expression involving innate immunity is strongly associated with IL32B genotype and response to PEG-IFN·/RBV。Both IL32B minor allele and higher RIG-land ISG15 expressions and RIG-I/IPS-1 ratio are independent factors for NVR。
英文摘要
Innate immunity plays an important role in host antiviral response to hepatitis C viral (HCV) infection. Recently, single nucleotide polymorphism (SNP) of IL28B and host response to pegylated interferon・(PEG-IFN・)and ribavirin (RBV) were shown to be strongly associated. We aimed to determine the gene expression involving innate immunity in IL28B genotypes and elucidate its relation to response to antiviral treatment. We genotyped IL28B SNPs (rs8099917 and rs12979860) in 88 chronic hepatitis C patients treated with PEG-IFN・-2b/RBV and quantified expressions of viral sensors (RIG-I, MDA5, and LGP2), adaptor molecule (IPS-1), related ubiquitin E3-ligase (RNF125), modulators (ISG15 and USP18), and IL28 (IFN・). Both IL28B SNPs were 100% identical ; 54 patients possessed rs8099917 TT/rs12979860 CC (IL28B major patients) and 34 possessed rs8099917 TG/rs12979860 CT (IL28B minor patients). Hepatic expressions of viral sensors and modulators in IL28B minor patients were significantly up-regulated compared with that in IL28B major patients (~3.3 fold, p<0.001). However, expression of IPS-1 was significantly lower in IL28B minor patients (1.2 fold, p=0.028). Hepatic expressions of viral sensors and modulators were significantly higher in non-virological responders (NVR) than that in others despite stratification by IL28B genotype (~2. 6 fold, p<0.001). Multivariate and ROC analyses indicated that higher RIG-I and ISG15 expressions and RIG-I/IPS-1 expression ratio were independent factors for NVR. Conclusion : Gene expression involving innate immunity is strongly associated with IL28B genotype and response to PEG-IFN・/RBV. Both IL28B minor allele and higher RIG-land ISG15 expressions and RIG-I/IPS-1 ratio are independent factors for NVR.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene expression involving innate immunity and IL28B variation : its association with antiviral response in chronic hepatitis C.
涉及先天免疫和 IL28B 变异的基因表达:其与慢性丙型肝炎抗病毒反应的关联。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Asahina Y, et al]
通讯作者: et al
Dynamic response of innate immunity induced by telaprevir and PEG-IFN/RBV treatment and its association with virological response and HCV variants.
特拉匹韦和 PEG-IFN/RBV 治疗诱导的先天免疫的动态反应及其与病毒学反应和 HCV 变异的关联。
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Asahina Y, Hirayama I, Tamaki N, Yasui Y, Tanaka T, Sato M, Ueda K, Kuzuya T, Tsuchiya K, Nakanishi H, Itakura J, Kurosaki M, Izumi N]
通讯作者: Izumi N
細胞内ウイルスセンサーおよび自然免疫系制御分子とPEG-IFN/ribavirin併用療法の治療効果日本消化器病学会誌105巻A75 (2008.3)
细胞内病毒传感器和先天免疫系统调节分子以及PEG-IFN/利巴韦林联合疗法的治疗效果日本胃肠病学会杂志,第105卷,A75(2008.3)
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [朝比奈靖浩, 他]
通讯作者:
シンポジウムC型肝炎における抗ウイルス療法の近未来,PEG-IFS/RBV併用療法およびプロテアーゼ阻害薬投与中の自然免疫系遺伝子発現ブロファイルと治療効果
研讨会:丙型肝炎抗病毒治疗的近期前景、先天免疫系统基因表达谱以及 PEG-IFS/RBV 联合治疗和蛋白酶抑制剂给药期间的治疗效果
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [朝比奈靖浩, 田中博, 泉並木]
通讯作者: 泉並木
32
    Human iPS-derived hepatocyte-like progenitor cells susceptible for hepatitis B virus infection
    • 批准号:
      25670366
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      ASAHINA Yasuhiro
    • 依托单位:
    Pathogenesis of chronic hepatitis C and hepatocellular carcinoma and predictive factors determined by data mining
    • 批准号:
      18590724
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.57万
    • 财政年份:
      2006
    • 负责人:
      ASAHINA Yasuhiro
    • 依托单位:
    国内基金
    海外基金
    高危型HPV自然感染者抗体产生、持续、消除的动力学及临床意义研究
    • 批准号:
      82073562
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2020
    • 负责人:
      吴婷
    • 依托单位:
    SLE患者NKG2D+CD4+T细胞杀伤调节性T细胞及分子机制研究
    新疆慢性化脓性中耳炎细菌生物膜形成及其在自然免疫中的作用研究
    • 批准号:
      81560173
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      37.0万元
    • 批准年份:
      2015
    • 负责人:
      顾兴智
    • 依托单位:
    自然杀伤细胞在白癜风发病中的作用
    • 批准号:
      81171506
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2011
    • 负责人:
      周育文
    • 依托单位: